GO:0015233 pantothenate transmembrane transporter activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0015233 describes the molecular function that enables directed movement of pantothenate (vitamin B5) across a membrane.
Pantothenate is the precursor of coenzyme A, making its transport essential for cellular metabolism and energy production.
In mammals, the sodium-dependent multivitamin transporter (SLC5A6) mediates pantothenate uptake together with biotin and lipoate.
Bacterial pantothenate transporters often belong to the energy-coupling factor (ECF) family and use ATP hydrolysis for substrate translocation.
Mutations in SLC5A6 cause a rare neurometabolic disorder with developmental delay and brain iron accumulation.
CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect the physiological roles of pantothenate transporters.

Description

Pantothenate transmembrane transporter activity (GO:0015233) is a molecular function that enables the directed movement of pantothenate, the anion of pantothenic acid (vitamin B5), across biological membranes. This activity is critical because pantothenate is an essential precursor for coenzyme A (CoA), a central cofactor in fatty acid synthesis, the tricarboxylic acid cycle, and numerous acetylation reactions. Without efficient transport, cells cannot acquire sufficient pantothenate for CoA biosynthesis, leading to metabolic collapse. Researchers study this term to understand how organisms scavenge and distribute this vitamin, and how defects in transport contribute to human disease. The function is conserved from bacteria to humans, with distinct protein families mediating transport in different organisms.

pantothenate transmembrane transporter activity At A Glance

GO ID GO:0015233
GO term pantothenate transmembrane transporter activity
Ontology molecular_function
Synonym pantothenate transporter activity; vitamin B5 transmembrane transporter activity
Major function Enables the directed movement of pantothenate across a membrane
Substrate Pantothenate (vitamin B5)
Cofactor Sodium ions (in mammals) or ATP (in ECF transporters)
Related diseases SLC5A6-related neurometabolic disorder, neurodegeneration with brain iron accumulation
Research methods CRISPR knockout, knock-in, overexpression, transport assays, structural biology

What Is GO:0015233?

According to the Gene Ontology, GO:0015233 enables the directed movement of pantothenate across a membrane. Pantothenate is the anion of pantothenic acid, an amide of beta-alanine and pantoic acid, and a B complex vitamin that is a constituent of coenzyme A and is distributed ubiquitously in foods. This activity is synonymous with pantothenate transporter activity and vitamin B5 transmembrane transporter activity.

Why Is pantothenate transmembrane transporter activity Important in Cell Biology?

Pantothenate transmembrane transporter activity is essential for cellular metabolism because pantothenate is the obligatory precursor of coenzyme A (CoA), a cofactor required for fatty acid oxidation, the TCA cycle, and protein acetylation. In mammals, the sodium-dependent multivitamin transporter (SMVT, encoded by SLC5A6) mediates the uptake of pantothenate, biotin, and lipoate, linking vitamin transport to energy homeostasis. In bacteria, energy-coupling factor (ECF) transporters use ATP to drive pantothenate uptake, and their dysfunction impairs growth. Defects in pantothenate transport cause a rare but severe neurometabolic disorder characterized by developmental delay, seizures, and brain iron accumulation. Thus, understanding this activity is crucial for both basic cell biology and clinical genetics.
Pantothenate is a precursor of coenzyme A, which is indispensable for fatty acid synthesis and oxidation.
SLC5A6 mutations cause a neurometabolic disorder with brain iron accumulation and developmental delay.
Bacterial ECF transporters are potential antibiotic targets because they are essential for pantothenate uptake.
Transport activity influences cellular acetyl-CoA levels, impacting histone acetylation and gene expression.
Pantothenate transport is required for the biosynthesis of the iron-sulfur cluster and heme in some organisms.
The sodium-dependent multivitamin transporter also transports biotin and lipoate, affecting multiple metabolic pathways.
Structural studies of ECF transporters reveal mechanisms of energy coupling that can be exploited for drug design.
CRISPR screens can identify genes that regulate pantothenate transport and CoA homeostasis.

Molecular Mechanism of pantothenate transmembrane transporter activity

Substrate recognition and binding
In simple terms: The transporter first grabs pantothenate from one side of the membrane.
Pantothenate transporters recognize their substrate through specific binding pockets. In the bacterial ECF transporter, the substrate-binding component (S component) captures pantothenate with high affinity. In mammals, the sodium-dependent multivitamin transporter (SMVT) binds pantothenate in a sodium-dependent manner, with conserved residues forming the substrate pocket. Structural studies of a pantothenate transporter revealed that the S component undergoes conformational changes upon substrate binding, which is essential for subsequent translocation.
Energy coupling and translocation
In simple terms: The transporter uses energy to push pantothenate across the membrane.
Bacterial ECF transporters couple pantothenate transport to ATP hydrolysis by the A and A' components, which share a module with other ECF transporters. Two essential arginine residues in the T component are critical for energy coupling and transport activity. In mammals, SMVT uses the sodium gradient to drive pantothenate uptake, a mechanism common to the sodium/substrate symporter family. The transport cycle involves alternating access of the substrate-binding site from one side of the membrane to the other.
Regulation of transporter expression and activity
In simple terms: Cells can adjust how many transporters they make or how active they are.
The expression of SLC5A6 is regulated by nutritional status and hormonal signals, although specific transcription factors are not fully defined. In bacteria, the expression of ECF transporter genes is often controlled by riboswitches or regulatory proteins in response to pantothenate availability. Post-translational modifications may also modulate transporter activity, but this remains an active area of research.
Physiological role in coenzyme A biosynthesis
In simple terms: Once inside, pantothenate is used to build coenzyme A, a key metabolic helper.
After transport, pantothenate is phosphorylated by pantothenate kinase to initiate CoA biosynthesis. CoA is essential for the TCA cycle, fatty acid metabolism, and protein acetylation. Therefore, the activity of pantothenate transporters directly impacts cellular CoA levels and metabolic flux. In humans, SLC5A6-mediated transport is particularly important in tissues with high CoA demand, such as the brain and liver.

Key Genes Involved in GO:0015233 pantothenate transmembrane transporter activity

The following genes and proteins are directly involved in pantothenate transmembrane transporter activity or its regulation.
GeneMajor RoleResearch Relevance
SLC5A6Sodium-dependent multivitamin transporter mediating pantothenate, biotin, and lipoate uptakeMutations cause neurometabolic disorder; target for transport assays
SLC5A6 (human)Placental Na+-dependent multivitamin transporterCloned and functionally expressed; gene structure and chromosomal localization determined
panT (bacterial)Pantothenate transporter in bacteriaModel for ECF transporter mechanism
ecfAATPase component of ECF transportersEnergy coupling for pantothenate transport
ecfA'ATPase component sharing module with ECF transportersStructural and functional studies
ecfTTransmembrane component of ECF transportersEssential arginine residues for transport
ecfSSubstrate-binding component of ECF transportersBinds pantothenate with high affinity
SLC5A6 variantsPathogenic variants causing SLC5A6-related disorderClinical genetics and functional studies
SMVTSodium-dependent multivitamin transporter proteinFunctional characterization in mammalian cells
PANK1Pantothenate kinase 1, first enzyme in CoA biosynthesisDownstream of transport; links to CoA metabolism
PANK2Pantothenate kinase 2, associated with NBIANeurodegeneration with brain iron accumulation
PANK3Pantothenate kinase 3CoA biosynthesis regulation
SLC5A6 (rat)Rat sodium-dependent multivitamin transporterCloning and functional expression
SLC5A6 (mouse)Mouse ortholog of SMVTModel for knockout studies
SLC5A6 (zebrafish)Zebrafish orthologDevelopmental studies
SLC5A6 (Drosophila)Fruit fly orthologGenetic studies of transport
SLC5A6 (C. elegans)Nematode orthologTransport and metabolism research
SLC5A6 (yeast)Yeast pantothenate transporterFungal model for transport

How Is pantothenate transmembrane transporter activity Regulated?

The activity of pantothenate transporters is regulated at multiple levels. In mammals, SLC5A6 expression is influenced by nutritional status, with pantothenate deficiency leading to upregulation of transport activity. Hormonal signals such as insulin may also modulate transport, although the exact mechanisms are not fully elucidated. In bacteria, the expression of ECF transporter genes is controlled by pantothenate-responsive riboswitches or regulatory proteins, ensuring adequate uptake. Additionally, the activity of the transporter can be regulated by post-translational modifications, such as phosphorylation, but this requires further investigation.

pantothenate transmembrane transporter activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
SLC5A6Neurometabolic disorder with brain iron accumulationKnockout mouse, patient-derived fibroblasts
SLC5A6Developmental delay and seizuresZebrafish knockout, iPSC-derived neurons
PANK2Neurodegeneration with brain iron accumulationKnockout mouse, Drosophila
SLC5A6Biotin and lipoate transport deficiencyCell lines with point mutations
SLC5A6Cancer cell proliferationOverexpression in cancer cell lines
SLC5A6-related neurometabolic disorder
Biallelic variants in SLC5A6 cause a rare neurometabolic disorder characterized by developmental delay, seizures, microcephaly, and brain iron accumulation. These variants impair the transport of pantothenate, biotin, and lipoate, leading to metabolic crises and neurological regression. The phenotypic spectrum has been expanded by novel variants, highlighting the importance of early diagnosis and potential treatment with vitamin supplementation.
Neurodegeneration with brain iron accumulation (NBIA)
Defects in pantothenate transport can lead to secondary CoA deficiency, which is linked to NBIA. While the classic NBIA gene is PANK2, mutations in SLC5A6 also result in brain iron accumulation, suggesting a shared metabolic pathway. This connection underscores the importance of pantothenate transport in neuronal survival and iron homeostasis.
Cancer metabolism
Rapidly proliferating cancer cells have increased demand for CoA to support fatty acid synthesis and histone acetylation. Upregulation of pantothenate transporters, such as SLC5A6, may enhance pantothenate uptake to meet this demand. Targeting pantothenate transport could therefore be a potential therapeutic strategy, although direct evidence in cancer models is still emerging.

From pantothenate transmembrane transporter activity-Related Genes to Experimental Models

Research QuestionSuitable Model
What is the effect of SLC5A6 loss on CoA levels?CRISPR knockout in HEK293 or HeLa cells
How do patient variants affect transport activity?Point mutation knock-in in cell lines
Can wild-type SLC5A6 rescue the phenotype?Knock-in of wild-type cDNA
Where is SLC5A6 localized in neurons?Tagged knock-in with fluorescent protein
Does overexpression increase pantothenate uptake?Overexpression in mammalian cells
What genes regulate pantothenate transport?CRISPR library screening

How to Study the pantothenate transmembrane transporter activity Process

MethodWhat It MeasuresTypical Application
Radiolabeled uptake assayTransport activityKinetic analysis of SLC5A6 variants
Cryo-EMProtein structureMechanistic studies of ECF transporters
CRISPR knockout screenGene essentialityIdentification of pantothenate transport regulators
MetabolomicsIntracellular metabolite levelsCoA quantification in knockout cells
RNA-seqGene expression changesTranscriptional response to pantothenate deprivation
Western blotProtein expressionValidation of knockout or overexpression
ImmunofluorescenceSubcellular localizationLocalization of tagged transporters
Site-directed mutagenesisResidue functionTesting essential arginines in ECF transporters
Transport assays
Radiolabeled pantothenate uptake assays are the gold standard for measuring pantothenate transmembrane transporter activity. Cells expressing the transporter of interest are incubated with [3H]pantothenate, and uptake is measured by scintillation counting. This method can determine kinetic parameters such as Km and Vmax, and can be adapted for high-throughput screening.
Structural biology
X-ray crystallography and cryo-electron microscopy have been used to solve the structure of bacterial pantothenate transporters, revealing the architecture of the ECF module and substrate-binding site. These structures provide insights into the transport mechanism and can guide drug design.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate pantothenate transport or CoA homeostasis. Cells are cultured in low pantothenate conditions, and sgRNA enrichment is analyzed by next-generation sequencing. This approach can uncover novel transporters or regulatory pathways.
Metabolomics and flux analysis
Mass spectrometry-based metabolomics can quantify intracellular pantothenate, CoA, and related metabolites. Stable isotope tracing with 13C-pantothenate can measure flux through CoA biosynthesis, providing a functional readout of transport activity.

How CRISPR Can Be Used to Study GO:0015233 pantothenate transmembrane transporter activity

Knockout

CRISPR knockout of SLC5A6 or bacterial pantothenate transporter genes can abolish pantothenate uptake, leading to CoA depletion and growth arrest. These models are valuable for studying the essentiality of the transporter and for identifying compensatory pathways. Knockout cell lines can be used in transport assays to confirm specificity.

Point Mutation

Point mutations identified in patients with SLC5A6-related disorder can be introduced into cell lines using CRISPR prime editing or homology-directed repair. These models allow functional characterization of variants, such as those affecting sodium binding or substrate recognition. They are crucial for establishing genotype-phenotype correlations.

Knock-in

Knock-in of tagged versions of pantothenate transporters (e.g., GFP or HA) enables visualization and biochemical purification. This approach can reveal subcellular localization and interaction partners. Knock-in of wild-type cDNA can also rescue knockout phenotypes, confirming specificity.

Overexpression

Overexpression of SLC5A6 or bacterial pantothenate transporters in mammalian or bacterial cells can increase pantothenate uptake and CoA levels. This is useful for producing large amounts of protein for structural studies or for screening inhibitors. Overexpression models can also test whether increased transport promotes proliferation.

How EDITGENE Supports pantothenate transmembrane transporter activity Research

Researchers studying pantothenate transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in transport, metabolism, or disease. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for pantothenate transmembrane transporter activity research.

Frequently Asked Questions About pantothenate transmembrane transporter activity

It is a molecular function (GO:0015233) that enables the directed movement of pantothenate, also known as vitamin B5, across a membrane.
Key genes include SLC5A6 in mammals, which encodes the sodium-dependent multivitamin transporter, and bacterial genes such as panT and ecfA, ecfA', ecfT, and ecfS for ECF transporters.
SLC5A6 encodes a sodium-dependent multivitamin transporter that mediates the uptake of pantothenate, biotin, and lipoate into cells.
In mammals, transport is driven by the sodium gradient through SLC5A6; in bacteria, ECF transporters use ATP hydrolysis to drive pantothenate uptake.
Mutations in SLC5A6 cause a neurometabolic disorder with developmental delay, seizures, and brain iron accumulation.
Symptoms include developmental delay, seizures, microcephaly, and brain iron accumulation, often presenting in infancy.
Common methods include radiolabeled uptake assays, structural biology, CRISPR screens, and metabolomics.
Model organisms include bacteria (e.g., E. coli), yeast, zebrafish, Drosophila, and mice, as well as human cell lines.
Yes, bacterial ECF transporters are essential for growth and are considered potential antibiotic targets; in cancer, targeting pantothenate uptake may inhibit proliferation.
The sodium-dependent multivitamin transporter (SMVT, SLC5A6) is a specific mammalian protein that exhibits pantothenate transporter activity, while pantothenate transporter is a general functional term.

Conclusion

Pantothenate transmembrane transporter activity (GO:0015233) is a fundamental molecular function required for vitamin B5 uptake and coenzyme A biosynthesis. Its dysregulation leads to severe neurometabolic disorders, and it represents a promising target for antibacterial and anticancer therapies. Continued research using CRISPR models and advanced structural techniques will further illuminate its mechanisms and therapeutic potential.

References

  1. 1. Zhang M et al.. 2014. Structure of a pantothenate transporter and implications for ECF module sharing and energy coupling of group II ECF transporters.. Proc Natl Acad Sci U S A 111(52):18560-5 PMID: 25512487
  2. 2. Jung H. 2002. The sodium/substrate symporter family: structural and functional features.. FEBS Lett 529(1):73-7 PMID: 12354616
  3. 3. Holling T et al.. 2022. Novel biallelic variants expand the SLC5A6-related phenotypic spectrum.. Eur J Hum Genet 30(4):439-449 PMID: 35013551
  4. 4. Prasad PD et al.. 2000. Structure and function of mammalian sodium-dependent multivitamin transporter.. Curr Opin Clin Nutr Metab Care 3(4):263-6 PMID: 10929671
  5. 5. Prasad PD et al.. 1998. Cloning and functional expression of a cDNA encoding a mammalian sodium-dependent vitamin transporter mediating the uptake of pantothenate, biotin, and lipoate.. J Biol Chem 273(13):7501-6 PMID: 9516450
  6. 6. Wang H et al.. 1999. Human placental Na+-dependent multivitamin transporter. Cloning, functional expression, gene structure, and chromosomal localization.. J Biol Chem 274(21):14875-83 PMID: 10329687
  7. 7. Neubauer O et al.. 2009. Two essential arginine residues in the T components of energy-coupling factor transporters.. J Bacteriol 191(21):6482-8 PMID: 19717603
Contact Us
*
*
*
*
How did you hear about us: